Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity

Kidney International

Volumn 65, Issue 6, 2004, Pages 2041-2053

  Mizui, Masayuki ^b   Isaka, Yoshitaka ^a   Takabatake, Yoshitsugu ^b   Mizuno, Sinya ^b   Nakamura, Toshikazu ^b   Ito, Takahito ^b   Imai, Enyu ^b   Hori, Masatsugu ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Cyclosporine; Electroporation; Gene therapy; HGF

Indexed keywords

CYCLOSPORIN A; MESSENGER RNA; PROTEIN BCL 2; PROTEIN KINASE B; RECOMBINANT GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL BASED GENE THERAPY; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ELECTROPORATION; GENE TRANSFER; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; KIDNEY NECROSIS; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; SODIUM RESTRICTION;

EID: 2442681478     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00625.x     Document Type: Article

References (30)

1. BENNETT WM: Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 34:515-519, 1996
2. OPELZ G, DOHLER B: Cyclosporine and long-term kidney graft survival. Transplantation 72:1267-1273, 2001
3. ANDOH TF, BENNETT WM: Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 7:265-270, 1998
4. SHIHAB FS: Cyclosporine nephropathy: Pathophysiology and clinical impact. Semin Nephrol 16:536-547, 1996
5. MYERS BD, Ross J, NEWTON L, et al: Cyclosporine-associated chronic nephropathy. N Engl J Med 311:699-705, 1984
6. THOMAS SE, ANDOH TF, PICHLER RH, et al: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897-908, 1998
7. SHIHAB FS, ANDOH TF, TANNER AM, et al: Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int 49:1141-1151, 1996
8. NAKAMURA T, NISHIZAWA T, HAGIYA M, et al: Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443, 1989
9. NAKAMURA T, TERAMOTO H, ICHIHARA A: Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 83:6489-6493, 1986
10. MATSUMOTO K, NAKAMURA T: Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases. Kidney Int 59:2023-2038, 2001
11. AMAIKE H, MATSUMOTO K, OKA T, et al: Preventive effect of hepatocyte growth factor on acute side effects of cyclosporin A in mice. Cytokine 8:387-394, 1996
12. MILLER SB, MARTIN DR, KISSANE J, et al. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 266:F129-F134, 1994
13. LIU Y: Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. Am J Physiol 277:F624-F633, 1999
14. MIZUNO S, MATSUMOTO K, NAKAMURA T: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 59:1304-1314, 2001
15. LIU ML, MARS WM, ZARNEGAR R, et al: Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver. Am J Pathol 144:129-140, 1994
16. NAKAMURA H, ISAKA Y, TSUJIE M, et al: Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis. Kidney Int 59:2134-2145, 2001
17. TSUJIE M, ISAKA Y, NAKAMURA H, et al: Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 12:949-954, 2001
18. NAKAMURA H, ISAKA Y, TSUJIE M, et al: Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats. Gene Ther 9:495-502, 2002
19. IGAWA T, MATSUMOTO K, KANDA S, et al: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 265:F61-F69, 1993
20. MIZUNO S, KUROSAWA T, MATSUMOTO K, et al: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 101:1827-1834, 1998
21. ISHIBASHI K, SASAKI S, SAKAMOTO H, et al: Hepatocyte growth factor is a paracrine factor for renal epithelial cells: Stimulation of DNA synthesis and NA,K-ATPase activity. Biochem Biophys Res Commun 182:960-965, 1992
22. ISLAM M, BURKE JF, JR., MCGOWAN TA, et al. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Kidney Int 59:498-506, 2001
23. NAKANO N, MORISHITA R, MORIGUCHI A, et al: Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: Potential role of HGF in cardiovascular disease. Hypertension 32:444-451, 1998
24. HONG F, NGUYEN VA, SHEN X, et al: Rapid activation of protein kinase B/Akt has a key role in antiapoptotic signaling during liver regeneration. Biochem Biophys Res Commun 279:974-979, 2000
25. DATTA SR, BRUNET A, GREENBERG ME: Cellular survival: A play in three Akts. Genes Dev 13:2905-2927, 1999
26. DATTA SR, DUDEK H, TAO X, et al: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241, 1997
27. WOLF G, THAISS F, STAHL RA: Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 60:237-241, 1995
28. SHIHAB FS, YAMAMOTO T, NAST CC, et al: Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 6:286-294, 1995
29. AIHARA H, MIYAZAKI J: Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867-870, 1998
30. VITADELLO M, SCHIAFFINO MV, PICARD A, et al: Gene transfer in regenerating muscle. Hum Gene Ther 5:11-18, 1994